Business Standard Laurus Labs jumps 4% on huge volumes; Motilal projects 30% further upside
Motilal Oswal remains positive on Laurus due to its strengthening position in gaining CDMO contracts, the addition of a growth lever in the generics space, and a steady ARV business.